Today marks an exciting step forward in how clinical research sites identify and enroll patients.

We’re proud to announce our partnership with Cardea Health, embedding their AI-powered ScreenFLOW solution directly into SiteCentric as a native, white-labeled capability, accessible through single sign-on inside our marketplace.

Sites don’t need more tools. They need less friction.

By embedding AI-driven patient screening directly into existing SiteCentric workflows, we’re eliminating double logins, reducing manual chart review, and helping site teams focus on what actually moves trials forward: enrolling the right patients, faster.

For sponsors and CROs, this means:

-Faster, more reliable feasibility insights
-Stronger enrollment performance
-Accelerated site activation timelines

For sites, it means AI-powered screening that’s operationally invisible. No workflow disruption, no added training burden, no extra systems to manage.

This partnership reflects what we believe deeply at SiteCentric: the future of clinical research infrastructure is embedded, interoperable, and built around site reality.

We are grateful to the Cardea Health team for their shared commitment to operational simplicity, and excited to see our first network, ClinSurge Research, lead the way with this integrated capability.